Satsuma Pharmaceuticals, Inc.
$83 Million - Initial Public OfferingJoint Bookrunner
$151 Million - Follow-OnJoint Bookrunner
Turning Point Therapeutics, Inc.
$203 Million - Follow-OnJoint Bookrunner
Medical Supplies and Devices / Survey Highlights Market Share Gain Potential is Real for Spine Robotics Players
Biopharma / Are Generic Deflation Trends Finally Starting to Improve?
ABBV / Upgrading the New Cash King – More Diversified, More Durable, Cheaper, OP, $88 / Outperform